Search results
Leadership Team. Onconova Therapeutics is led by a leadership team with significant expertise in targeted cancer therapeutics, clinical development, and commercialization. Steven M. Fruchtman, M.D. President & CEO. Dr. Fruchtman joined Onconova in January 2015 as Chief Medical Officer.
Dec 19, 2022 · “It is my pleasure to welcome Peter and Trafford to our Board,” said Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova. “Their track record of successfully building...
Dr. Atadja joins Onconova’s Board with over two decades of experience in the pharmaceutical industry. He is currently the Chief Scientific Officer (CSO) of CommBio Therapeutics, a biotechnology...
- Onconova Therapeutics, Inc.
Dr. Peter Atadja's life story is enthralling; from his pharmacy school at the Kwame Nkrumah University of Science and Technolgy in Kumasi, Ghana, to the Hebr...
- 86 min
- 536
- Ebere Igboko
Dec 19, 2022 · NEWTOWN, Pa., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced the appointments of Peter Atadja, Ph.D., and Trafford Clarke, Ph.D., as independent members of the Company’s Board of Directors. “It is my ...
May 20, 2010 · Dr Peter Atadja, a Ghanaian Pharmacist is developing an anti-cancer therapy that would hit the market next year. The drug, which is at the trial stages, is awaiting certification from the World Health Organization before it is branded.
People also ask
Who is Dr Fruchtman & Peter atadja?
Who is Peter atadja?
Who is Dr atadja?
Who is Dr Fruchtman?
Who is Dr atadja & what did he do before joining commbio?
Peter ATADJA, Chief Scientific Officer | Cited by 15,318 | | Read 234 publications | Contact Peter ATADJA.